IBA Dosimetry, established in 1974, stands as a leading provider in the domain of Quality Assurance for radiation therapy and medical imaging. The company's slogan, "Integrated & Independent Quality Assurance in Radiation Therapy and Medical Imaging," encapsulates its commitment to high-precision solutions aimed at improving cancer care.
Headquartered in Germany with subsidiaries in Herndon, VA, USA and Beijing, China, IBA Dosimetry offers a comprehensive suite of innovative instruments and software. These solutions empower medical physicists and radiologists to conduct essential QA and calibration procedures, ensuring patient safety and precise treatment.
Positioned as the world's number one dosimetry solution provider in installed systems, the company targets industries including Health Care, Manufacturing, Medical Devices, and Pharmaceutical. Despite no recent investment disclosures, its strong market position and continuous innovation make it an attractive prospect for potential investors.